26.77
price down icon1.37%   -0.375
 
loading
Precedente Chiudi:
$27.14
Aprire:
$26.42
Volume 24 ore:
3.37M
Relative Volume:
0.34
Capitalizzazione di mercato:
$10.41B
Reddito:
$3.14B
Utile/perdita netta:
$-3.36B
Rapporto P/E:
-3.0659
EPS:
-8.73
Flusso di cassa netto:
$-4.03B
1 W Prestazione:
-0.23%
1M Prestazione:
+7.08%
6M Prestazione:
+8.31%
1 anno Prestazione:
-51.17%
Intervallo 1D:
Value
$26.24
$26.94
Intervallo di 1 settimana:
Value
$26.01
$28.48
Portata 52W:
Value
$23.15
$57.69

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
5,800
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2025-08-01
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Confronta MRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRNA
Moderna Inc
26.76 10.60B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.48 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
486.06 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.06 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
840.69 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
316.31 34.93B 4.56B -176.77M 225.30M -1.7177

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Citigroup Neutral
2025-02-18 Downgrade Barclays Overweight → Equal Weight
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
10:01 AM

Moderna to Present Promising Phase 1/2 Clinical and Safety Data for Cancer Antigen Therapy mRNA-4359 at ESMO 2025 - Insider Monkey

10:01 AM
pulisher
05:57 AM

Q3 Earnings Estimate for Moderna Issued By Leerink Partnrs - MarketBeat

05:57 AM
pulisher
Oct 16, 2025

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - Monroe Evening News

Oct 16, 2025
pulisher
Oct 16, 2025

Moderna Inc. Stock Advances 5.5%, Outperforms Peers - 富途牛牛

Oct 16, 2025
pulisher
Oct 15, 2025

How Moderna Inc. (MRNA) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Oct 15, 2025
pulisher
Oct 15, 2025

Why Moderna Might Be a One-Hit Wonder - The Globe and Mail

Oct 15, 2025
pulisher
Oct 15, 2025

Why Moderna Might Be a One-Hit Wonder - The Motley Fool

Oct 15, 2025
pulisher
Oct 15, 2025

Intraday pattern recognizer results for Moderna Inc.Quarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Leerink Partners Adjusts Price Target on Moderna to $16 From $15, Maintains Underperform Rating - MarketScreener

Oct 15, 2025
pulisher
Oct 15, 2025

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - The Marion Star

Oct 15, 2025
pulisher
Oct 14, 2025

Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com

Oct 14, 2025
pulisher
Oct 14, 2025

Moderna: Q3 Earnings PreviewI Fear A Halloween Horror Show (Downgrade) (NASDAQ:MRNA) - Seeking Alpha

Oct 14, 2025
pulisher
Oct 14, 2025

Lobbying Update: $80,000 of MODERNA US INC. lobbying was just disclosed - Quiver Quantitative

Oct 14, 2025
pulisher
Oct 14, 2025

Moderna (MRNA) Tops List of Most Shorted S&P 500 Stocks - GuruFocus

Oct 14, 2025
pulisher
Oct 14, 2025

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories - Norwich Bulletin

Oct 14, 2025
pulisher
Oct 14, 2025

How to use Fibonacci retracement on Moderna Inc.July 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Key facts: Moderna faces cash flow challenges; stock rises on therapy data - TradingView

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna (MRNA) Stock Trades Up, Here Is Why - The Globe and Mail

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna’s Off-The-Shelf Cancer Immunotherapy Shows Early Promise - insights.citeline.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Moderna Inc. meeting your algorithmic filter criteriaRate Hike & Fast Exit Strategy with Risk Control - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients - Benzinga

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna (MRNA) Unveils Promising Data on mRNA-4359 for Melanoma Treatment - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

What’s next for Moderna Inc. stock priceJuly 2025 Highlights & Consistent Growth Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna (MRNA) Tops Healthcare Short Interest Rankings - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

Respiratory Syncytial Virus (RSV) Market Explosion To hit - openPR.com

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna Claims Early Victory for Cancer Antigen in Melanoma - BioSpace

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility With A 65% Potential Upside - DirectorsTalk Interviews

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna reports early cancer therapy data at medical conference - StreetInsider

Oct 13, 2025
pulisher
Oct 13, 2025

KLP Kapitalforvaltning AS Sells 34,400 Shares of Moderna, Inc. $MRNA - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna, Inc. $MRNA Shares Bought by Janney Montgomery Scott LLC - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress - Times Herald

Oct 13, 2025
pulisher
Oct 12, 2025

Moderna says it presents promising early data for investigational cancer antigen therapy - MarketScreener

Oct 12, 2025
pulisher
Oct 12, 2025

67% ORR in PD-L1+ tumors — Moderna's mRNA-4359 shows 24% overall ORR in CPI‑R/R melanoma at ESMO - Stock Titan

Oct 12, 2025
pulisher
Oct 11, 2025

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans - Shreveport Times

Oct 11, 2025
pulisher
Oct 11, 2025

Moderna (NASDAQ:MRNA) Given New $32.00 Price Target at Morgan Stanley - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

MRNA: Morgan Stanley Raises Price Target for Moderna | MRNA Stoc - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

Covid-19 Vaccine Recommendations | Moderna - OurQuadCities

Oct 10, 2025
pulisher
Oct 10, 2025

Moderna assists with the evolving landscape of COVID-19 vaccine - KHGI

Oct 10, 2025
pulisher
Oct 10, 2025

AstraZeneca ups investment in Virginia; Moderna vets launch VC fund - BioPharma Dive

Oct 10, 2025
pulisher
Oct 10, 2025

Moderna (NASDAQ:MRNA) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism - Newport Daily News

Oct 10, 2025
pulisher
Oct 09, 2025

Should Moderna's (MRNA) Improved Revenue Trends Prompt New Action From Investors? - Yahoo Finance

Oct 09, 2025

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$36.60
price up icon 0.68%
$88.14
price up icon 0.95%
$33.05
price up icon 0.82%
$105.05
price down icon 0.03%
$163.24
price up icon 0.11%
biotechnology ONC
$315.43
price down icon 0.68%
Capitalizzazione:     |  Volume (24 ore):